A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Pulmonary Arterial Hypertension
In brief
This is an exploratory Phase 2a, randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of RVT-1201 in patients with pulmonary arterial hypertension (PAH).
Key facts
- Study ID
- NCT03924154
- Run by
- Altavant Sciences GmbH
- People needed
- 3
- Starts
- 2019-08-01
- Expected to finish
- 2020-02-24
- Last updated by the study team
- 2020-03-09
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pulmonary Associates, PA — Phoenix, Arizona, United States
- University of California Davis Medical Center — Sacramento, California, United States
- SBPA Research LLC — Santa Barbara, California, United States
- University of Colorado — Aurora, Colorado, United States
- George Washington Medical Faculty Associates - Pulmonary Hypertension Program — Washington D.C., District of Columbia, United States
- University of Florida — Gainesville, Florida, United States
- San Marcus Research Clinic, Inc. — Miami Lakes, Florida, United States
- Central Florida Pulmonary Group, P.A. — Orlando, Florida, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Kentuckiana Pulmonary Research Center — Louisville, Kentucky, United States
- Louisiana State University Health Sciences Center — New Orleans, Louisiana, United States
- Boston Children's Hospital — Boston, Massachusetts, United States
- Baystate Medical Center — Springfield, Massachusetts, United States
- Pulmonary Research Institute of Southeast Michigan — Farmington Hills, Michigan, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- Oregon Health & Science University — Portland, Oregon, United States
- University of Texas Southwestern Medical Center — Dallas, Texas, United States
- University of Texas Health Science Center at Houston, McGovern Medical School — Houston, Texas, United States
- University of Calgary — Calgary, Alberta, Canada
- University of Alberta — Edmonton, Alberta, Canada
- London Health Sciences Centre — London, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.